This article not only establishes the association of iron deficiency, chronic inflammation, erythropoietin levels, and the renin-angiotensin-aldosterone system with the development of anemia in heart failure patients but also sheds a light on the latest developments in the management, with the help of multiple evidence-based researches, of such patients. The gene discussed is EPO; the disease is anemia.